Lumida
/RDVT
⌘K
Red Violet Inc

Red Violet Inc

RDVT
$75.02USD+2.70%+1.97 today

MARKET CAP

1.2B

P/E (TTM)

77.3x

FWD P/E

DAY RANGE

$74 – $75

52W RANGE

$33
$77

AI Summary

Stalk
Buy NowMedium

RDVT remains in a clear Stage 2 advance, with higher highs and higher lows above rising EMAs confirming sustained demand. After a shallow pullback into the 20-day EMA, price is holding support and tracking tightly along the EMA stack, while RSI and options sentiment show no exhaustion. The medium-term bias is bullish, and short-term timing aligns with a pullback entry. Buy now on this consolidation near the EMA20 and prior breakout zone, risking a break below the 50-day SMA as the key invalidation.

  • Q2 revenue $26.7m (+23% YoY), net income $5.0m (+85%) and adj. EPS $0.50
  • 76% gross margin and 42% adjusted EBITDA margin reflect strong pricing power
  • Shares at ~$71.19 trade ~67% premium to $42.61 fair value estimate
Full analysis →

Buying

4

institutions

Selling

4

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY950.76 K60.58 M+40.37 K+92.3%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY110.27 K7.03 M+29.44 K+151.2%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY85.37 K5.33 M+26.79 K+164.6%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY62.31 K3.97 M+7.90 K+110.9%0.00%
MG

Man Group Plc

Q2 2026

SELL41.09 K2.62 M+-44.59 K-11.7%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL25.60 K1.63 M+-87.85 K-58.4%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-68.31 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-7.54 K-100.0%0.00%